Asia Pacific Automated And Closed Cell Therapy Processing Systems Market Size & Outlook

The automated and closed cell therapy processing systems market in Asia Pacific is expected to reach a projected revenue of US$ 888.5 million by 2030. A compound annual growth rate of 20.7% is expected of Asia Pacific automated and closed cell therapy processing systems market from 2025 to 2030.
Revenue, 2024 (US$M)
$292.5
Forecast, 2030 (US$M)
$888.5
CAGR, 2025 - 2030
20.7%
Report Coverage
Asia Pacific

Asia Pacific automated and closed cell therapy processing systems market, 2018-2030 (US$M)

Asia

Related Markets

Asia Pacific automated and closed cell therapy processing systems market highlights

  • The Asia Pacific automated and closed cell therapy processing systems market generated a revenue of USD 292.4 million in 2024.
  • The market is expected to grow at a CAGR of 20.7% from 2025 to 2030.
  • In terms of segment, pre-commercial/ r&d scale was the largest revenue generating scale in 2024.
  • Commercial Scale is the most lucrative scale segment registering the fastest growth during the forecast period.
  • Country-wise, China is expected to register the highest CAGR from 2025 to 2030.

Asia Pacific data book summary

Market revenue in 2024USD 292.4 million
Market revenue in 2030USD 888.6 million
Growth rate20.7% (CAGR from 2025 to 2030)
Largest segmentPre-commercial/ r&d scale
Fastest growing segmentCommercial Scale
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPre-commercial/ R&D Scale, Commercial Scale
Key market players worldwideMiltenyi Biotec, Lonza Group Ltd, Fresenius SE & Co KGaA, Cytiva, Terumo Corp, Sartorius AG, ThermoGenesis Holdings Inc, Thermo Fisher Scientific Inc, Biospherix, Cellares

Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 20.8% of the global automated and closed cell therapy processing systems market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 888.6 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Automated and Closed Cell Therapy Processing Systems Market Companies

Name Profile # Employees HQ Website

Asia Pacific automated and closed cell therapy processing systems market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to automated and closed cell therapy processing systems market will help companies and investors design strategic landscapes.


Pre-commercial/ r&d scale was the largest segment with a revenue share of 92.2% in 2024. Horizon Databook has segmented the Asia Pacific automated and closed cell therapy processing systems market based on pre-commercial/ r&d scale, commercial scale covering the revenue growth of each sub-segment from 2018 to 2030.


Growing government and private investments, increasing healthcare needs, establishment of accelerated approval pathways are key drivers of the Asia Pacific market. Moreover, China is showed as the fast-growing market for cell therapy development.

Favorable regulatory scenario, mature infrastructure for clinical studies, and a booming ecosystem with government–industry collaboration is driving China’s cell and gene therapy development market. In addition, China has been ranked second in term clinical trials across the globe, with over 1,000 clinical trials either completed or ongoing.

Furthermore, Japan is anticipated to witness significant market growth due to rising clinical studies on cell therapies and the rising number of cell therapies advancing from clinical trials to regulatory approval. For instance, in October 2020, Novartis received approval from Japan’s Ministry of Health, Labor, and Welfare for the Foundation for Biomedical Research and Innovation to produce and supply Kymriah in the country.

Reasons to subscribe to Asia Pacific automated and closed cell therapy processing systems market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific automated and closed cell therapy processing systems market databook

  • Our clientele includes a mix of automated and closed cell therapy processing systems market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific automated and closed cell therapy processing systems market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific automated and closed cell therapy processing systems market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific automated closed cell therapy processing systems market report size, by country, 2018-2030 (US$M)

Asia Pacific Automated and Closed Cell Therapy Processing Systems Market Outlook Share, 2024 & 2030 (US$M)

Asia Pacific automated closed cell therapy processing systems market report size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more